You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Xuefei Guo1, Yang Zhao1, Xianle Rong2
1Institute of Systems Biomedicine, Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, NHC Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, 100191, China.
Methylcobalamin (MCB) reduces inflammation but weakens innate immunity. A new compound, Co7, balances these effects, offering a promising therapeutic for inflammatory diseases and COVID-19.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: